Sandra Coufal, Toragen, shares promising Phase I results showing dramatic HPV DNA reductions and tumor shrinkage, with Phase II set to confirm efficacy and safety. In an interview with PharmTech, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results